We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Outlines Criteria for Skipping Trial Consent in Emergencies
FDA Outlines Criteria for Skipping Trial Consent in Emergencies
December 11, 2014
New FDA requirements regarding emergency research on incapacitated patients stress that sponsors must attempt to get permission from the patient’s family to continue a trial that was started without consent and allow patients to opt out once they are conscious.